Early Detection of COPD Exacerbations Using Home Monitoring Device
Eligible age
21+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \>21) with physician-diagnosed COPD who are at high risk for exacerbations. The study will collect data from participants with COPD that will be analyzed using an AI-based algorithm to predict exacerbation events. The device's predictions will then be compared against clinically documented exacerbations to assess detection accuracy.
Sponsor: RespirAI US Inc
You may qualify if…
- ✓ Age \>21 years.
- ✓ Physician-diagnosed COPD at least 6 months prior to screening visit.
- ✓ Two or more moderate COPD exacerbations in the past 6 months or 1 severe exacerbation during the past 6 months.
- ✓ Free of exacerbation for 1 month before enrollment.
You may not qualify if…
- ✕ Unable or willing to sign an informed consent.
- ✕ Unable to complete the 6-minute walk test due to physical or mental health conditions.
- ✕ Patients with cardiac pacemaker, defibrillators, or other implanted electronic devices.
- ✕ Pregnancy
- ✕ Study clinician determines that the patient is unable or unwilling to comply with all study procedures.
Where it's recruiting
Omaha
Source: ClinicalTrials.gov · NCT07554352 · last updated 2026-08-10